Evidence map›Paper›PMID 9545244›Full record

ArticleThe EMBO journal1998

Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.

S L Nutt, A M Morrison, P Dörfler, A Rolink, M Busslinger

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 310 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Pleiotropy ofInternational journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Molecular Regulation of Differentiation in Early B-Lymphocyte Development.International journal of molecular sciences · 2018
    Review
  19. Synergistic cooperation and crosstalk betweenThe Journal of experimental medicine · 2017
    Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S L NuttResearch Institute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria.
A M Morrison
P Dörfler
A Rolink
M Busslinger
Research Institute of Molecular Pathology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Pax-5 gene codes for the transcription factor BSAP which is essential for the progression of adult B lymphopoiesis beyond an early progenitor (pre-BI) cell stage. Although several genes have been proposed to be regulated by BSAP, CD19 is to date the only target gene which has been genetically confirmed to depend on this transcription factor for its expression. We have now taken advantage of cultured pre-BI cells of wild-type and Pax-5 mutant bone marrow to screen a large panel of B lymphoid genes for additional BSAP target genes. Four differentially expressed genes were shown to be under the direct control of BSAP, as their expression was rapidly regulated in Pax-5-deficient pre-BI cells by a hormone-inducible BSAP-estrogen receptor fusion protein. The genes coding for the B-cell receptor component Ig-alpha (mb-1) and the transcription factors N-myc and LEF-1 are positively regulated by BSAP, while the gene coding for the cell surface protein PD-1 is efficiently repressed. Distinct regulatory mechanisms of BSAP were revealed by reconstituting Pax-5-deficient pre-BI cells with full-length BSAP or a truncated form containing only the paired domain. IL-7 signalling was able to efficiently induce the N-myc gene only in the presence of full-length BSAP, while complete restoration of CD19 synthesis was critically dependent on the BSAP protein concentration. In contrast, the expression of the mb-1 and LEF-1 genes was already reconstituted by the paired domain polypeptide lacking any transactivation function, suggesting that the DNA-binding domain of BSAP is sufficient to recruit other transcription factors to the regulatory regions of these two genes. In conclusion, these loss- and gain-of-function experiments demonstrate that BSAP regulates four newly identified target genes as a transcriptional activator, repressor or docking protein depending on the specific regulatory sequence context.

Indexed as

AnimalsAntigens, CDAntigens, CD19Antigens, SurfaceApoptosis Regulatory ProteinsB-LymphocytesCD79 AntigensCell MembraneDNA-Binding ProteinsGene Expression RegulationGenes, mycHematopoietic Stem CellsHumansInterleukin-7Lymphoid Enhancer-Binding Factor 1MiceAntigens, CDAntigens, CD19Antigens, SurfaceApoptosis Regulatory ProteinsCD79 AntigensCD79A protein, humanCd79a protein, mouseDNA-Binding ProteinsInterleukin-7LEF1 protein, humanLef1 protein, mouseLymphoid Enhancer-Binding Factor 1Nuclear ProteinsPAX5 protein, humanPax5 protein, mousePAX5 Transcription FactorPDCD1 protein, humanPdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, Antigen, B-CellTranscription Factors

Identifiers

PMID9545244
PMCPMC1170575
OpenAlexW2034427054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.